89bio Inc.

NASDAQ: ETNB · Real-Time Price · USD
9.22
0.12 (1.32%)
At close: Aug 15, 2025, 3:59 PM
9.23
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

89bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
38K 273K 240K 79K
Gross Profit
-38K -273K -240K -79K
Operating Income
-384.66M -151.2M 102.25M -89.74M
Interest Income
n/a n/a 2.16M 148K
Pretax Income
-366.39M -138.32M -102.01M -90.27M
Net Income
-367.08M -142.19M -102.03M -90.12M
Selling & General & Admin
39.62M 28.97M 21.45M 19.41M
Research & Development
345.04M 122.23M 80.8M 70.33M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
384.66M 151.2M 102.25M 89.74M
Interest Expense
3.79M 3.59M 1.92M 674K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
384.66M 151.2M 102.25M 89.74M
Income Tax Expense
692K 3.87M 19K -147K
Shares Outstanding (Basic)
104.71M 71.17M 34.81M 20.1M
Shares Outstanding (Diluted)
104.71M 71.17M 34.81M 20.1M
EPS (Basic)
-3.51 -2 -2.93 -4.48
EPS (Diluted)
-3.51 -2 -2.93 -4.48
EBITDA
-384.66M -134.46M -99.84M -90.19M
EBIT
-371.68M -134.74M -100.08M -90.27M
Depreciation & Amortization
-12.98M 273K 240K 79K